All In Biotech

Drug Trial Radar · NCT01179048

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events

Last checked: Nov 19, 2026Latest source record: Jul 17, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 9,341 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

9,341

Actual

Start

Aug 31, 2010

Primary completion

Dec 17, 2015

Study completion Dec 17, 2015

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Aug 10, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is conducted in Africa, Asia, Europe, and North and South America. The aim of this trial is to determine the long term effect of liraglutide on cardiovascular events in subjects with type 2 diabetes.

Conditions

  • Diabetes
  • Diabetes Mellitus, Type 2

Interventions

  • liraglutideDrug

    Maximum dose of 1.8 mg liraglutide, injected subcutaneously (under the skin) once daily. Administered in addition to the subject's standard treatment

  • placeboDrug

    Maximum dose of 1.8 mg placebo, injected subcutaneously (under the skin) once daily. Administered in addition to the subject's standard treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time From Randomisation to First Occurrence of Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke (a Composite Cardiovascular Outcome)Time frame: from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)

Locations

428 sites in 33 countries. Site status is shown where the registry gives one.

  • Novo Nordisk Investigational Site

    Alabaster, Alabama

  • Novo Nordisk Investigational Site

    Birmingham, Alabama

  • Novo Nordisk Investigational Site

    Birmingham, Alabama

  • Novo Nordisk Investigational Site

    Huntsville, Alabama

  • Novo Nordisk Investigational Site

    Mobile, Alabama

  • Novo Nordisk Investigational Site

    Tempe, Arizona

  • Novo Nordisk Investigational Site

    Little Rock, Arkansas

  • Novo Nordisk Investigational Site

    Little Rock, Arkansas

  • Novo Nordisk Investigational Site

    Anaheim, California

  • Novo Nordisk Investigational Site

    Cerritos, California

  • Novo Nordisk Investigational Site

    Escondido, California

  • Novo Nordisk Investigational Site

    Fresno, California

  • Novo Nordisk Investigational Site

    Los Angeles, California

  • Novo Nordisk Investigational Site

    Los Banos, California

  • Novo Nordisk Investigational Site

    Mission Hills, California

  • Novo Nordisk Investigational Site

    Montclair, California

  • Novo Nordisk Investigational Site

    San Diego, California

  • Novo Nordisk Investigational Site

    Tustin, California

  • Novo Nordisk Investigational Site

    Walnut Creek, California

  • Novo Nordisk Investigational Site

    Watsonville, California

  • Novo Nordisk Investigational Site

    Aurora, Colorado

  • Novo Nordisk Investigational Site

    Denver, Colorado

  • Novo Nordisk Investigational Site

    Newark, Delaware

  • Novo Nordisk Investigational Site

    Bradenton, Florida

  • Novo Nordisk Investigational Site

    Clearwater, Florida

  • Novo Nordisk Investigational Site

    DeLand, Florida

  • Novo Nordisk Investigational Site

    Fort Lauderdale, Florida

  • Novo Nordisk Investigational Site

    Kissimmee, Florida

  • Novo Nordisk Investigational Site

    Miami, Florida

  • Novo Nordisk Investigational Site

    Orlando, Florida

  • Novo Nordisk Investigational Site

    St. Petersburg, Florida

  • Novo Nordisk Investigational Site

    Tampa, Florida

  • Novo Nordisk Investigational Site

    West Palm Beach, Florida

  • Novo Nordisk Investigational Site

    Lawrenceville, Georgia

  • Novo Nordisk Investigational Site

    Roswell, Georgia

  • Novo Nordisk Investigational Site

    Chicago, Illinois

  • Novo Nordisk Investigational Site

    Chicago, Illinois

  • Novo Nordisk Investigational Site

    Chicago, Illinois

  • Novo Nordisk Investigational Site

    Crystal Lake, Illinois

  • Novo Nordisk Investigational Site

    Indianapolis, Indiana

Showing 40 of 428 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.